Phibro Animal Health (NASDAQ:PAHC) Rating Lowered to Hold at BidaskClub

Phibro Animal Health (NASDAQ:PAHC) was downgraded by equities research analysts at BidaskClub from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Friday, BidAskClub reports.

A number of other analysts have also recently issued reports on the company. Gabelli raised Phibro Animal Health from a “hold” rating to a “buy” rating and set a $42.00 target price for the company in a research note on Wednesday, May 8th. They noted that the move was a valuation call. ValuEngine cut shares of Verso from a “hold” rating to a “sell” rating in a research note on Thursday, May 23rd. Barclays reaffirmed a “hold” rating on shares of Bank of Montreal in a research note on Tuesday, June 11th. Zacks Investment Research raised shares of Triple-S Management from a “hold” rating to a “buy” rating and set a $26.00 price target for the company in a research note on Monday, April 29th. Finally, Guggenheim reaffirmed a “buy” rating and set a $95.00 price target (up from $90.00) on shares of VF in a research note on Thursday, May 23rd. Two investment analysts have rated the stock with a sell rating, four have issued a hold rating and one has assigned a buy rating to the stock. The company currently has a consensus rating of “Hold” and a consensus price target of $41.50.

NASDAQ PAHC opened at $30.51 on Friday. The business’s 50 day simple moving average is $30.35. Phibro Animal Health has a 52-week low of $27.32 and a 52-week high of $54.62. The company has a current ratio of 3.41, a quick ratio of 1.98 and a debt-to-equity ratio of 1.48. The company has a market cap of $1.23 billion, a PE ratio of 18.49, a price-to-earnings-growth ratio of 4.28 and a beta of 0.74.

Phibro Animal Health (NASDAQ:PAHC) last posted its earnings results on Monday, May 6th. The company reported $0.39 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.43 by ($0.04). Phibro Animal Health had a return on equity of 33.77% and a net margin of 8.12%. The business had revenue of $205.70 million for the quarter, compared to the consensus estimate of $214.94 million. During the same period in the previous year, the company posted $0.46 earnings per share. Phibro Animal Health’s revenue for the quarter was down 1.5% compared to the same quarter last year. Analysts anticipate that Phibro Animal Health will post 1.52 EPS for the current fiscal year.

Institutional investors and hedge funds have recently modified their holdings of the company. Oregon Public Employees Retirement Fund purchased a new position in Phibro Animal Health during the fourth quarter worth about $247,000. California Public Employees Retirement System raised its holdings in Phibro Animal Health by 34.5% during the fourth quarter. California Public Employees Retirement System now owns 46,524 shares of the company’s stock worth $1,496,000 after purchasing an additional 11,939 shares in the last quarter. New York State Common Retirement Fund raised its holdings in Phibro Animal Health by 12.8% during the fourth quarter. New York State Common Retirement Fund now owns 52,379 shares of the company’s stock worth $1,685,000 after purchasing an additional 5,947 shares in the last quarter. Texas Permanent School Fund raised its holdings in Phibro Animal Health by 4.5% during the fourth quarter. Texas Permanent School Fund now owns 13,225 shares of the company’s stock worth $425,000 after purchasing an additional 564 shares in the last quarter. Finally, Northern Trust Corp raised its holdings in Phibro Animal Health by 8.0% during the fourth quarter. Northern Trust Corp now owns 452,913 shares of the company’s stock worth $14,566,000 after purchasing an additional 33,656 shares in the last quarter. 50.19% of the stock is owned by institutional investors.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as a diversified animal health and mineral nutrition company primarily in the United States. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for a range of food animals, including poultry, swine, beef and dairy cattle, and aquaculture.

Read More: Understanding debt-to-equity ratio in fundamental analysis

Receive News & Ratings for Phibro Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.